BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7894623)

  • 1. Clinicopathological study of lymphomas in the central nervous system--with the reference to the recurrence and proliferative activity.
    Tanaka Y; Uematsu Y; Itakura T; Komai N
    Noshuyo Byori; 1994; 11(2):181-6. PubMed ID: 7894623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of proliferative activity in Wilms' tumour.
    Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
    Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome of patients with primary malignant lymphoma of the brain; relationship to the nucleolar organizer region].
    Nakasu S; Nakazawa T; Saito A; Matsuda M; Handa J
    No Shinkei Geka; 1992 May; 20(5):593-8. PubMed ID: 1598135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of proliferative cell nuclear antigen expression and clinical prognosis in gastric malignant lymphoma].
    Tsurumachi T; Gunji S; Suzuki T; Nagata M; Nakajima K; Matsubara H; Koide Y; Ochiai T; Isono K
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1781-5. PubMed ID: 8937488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [AgNOR analysis of astrocytoma in childhood].
    Haberland C; Martin H; Guski H; Hufnagl P; Vogel S
    Zentralbl Neurochir; 1996; 57(1):5-11. PubMed ID: 8900893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the treatment of malignant lymphoma of the brain--a report of Japan Lymphoma Radiation Therapy Group (JLRTG)].
    Niibe H; Tamaki Y; Watanabe S; Masaki N; Horiuchi J; Hayabuchi N; Kaneda K; Morita K
    Gan No Rinsho; 1988 Apr; 34(5):651-7. PubMed ID: 3385931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
    Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
    Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
    Tamaki M; Maeda S; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.
    Vargas-Roig LM; Fanelli MA; López LA; Gago FE; Tello O; Aznar JC; Ciocca DR
    Cancer Detect Prev; 1997; 21(5):441-51. PubMed ID: 9307847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary colorectal lymphomas.
    Wong MT; Eu KW
    Colorectal Dis; 2006 Sep; 8(7):586-91. PubMed ID: 16919111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary non-Hodgkin lymphomas of the CNS. Classification, tissue reaction and proliferative activity.
    Bergmann M; Kuchelmeister K; Edel G; Heinecke A
    Zentralbl Pathol; 1993 Mar; 139(1):37-44. PubMed ID: 8098955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system.
    Arai M; Sasaki A; Saito N; Nakazato Y
    Pathol Int; 2005 Mar; 55(3):122-9. PubMed ID: 15743320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
    Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
    J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.